We bring “miracles in medicine” to make a better future (mirai) in people's lives.
ABOUT USINNOVATIVE NEOBIOLOGICS
We use a simple, elegant technology called LassoGraft Technology® to extend the boundaries of biopharmaceuticals, creating new, innovative Neobiologics (multifunctional biopharmaceuticals) and bringing them to those who need them.
Portfolio
We build up a rich, varied portfolio by applying LassoGraft Technology® to a wide variety of modalities and therapeutic areas.
PORTFOLIOScience
LassoGraft Technology®, by grafting target-specific cyclic peptides onto any proteins in the body, transforms them into biologically active proteins, creating new biopharmaceutical Neobiologics.
SCIENCE- Speed
- Robustness and reliability
- Plug & Play
- Multifunctionality
Partnership
In drug development, we value collaboration with pharmaceutical companies. The essence of collaboration is to combine our partners’ drug development expertise and experience with our LassoGraft Technology®, to create cutting-edge biopharmaceuticals rapidly and deliver them to patients worldwide who need them.
PARTNERSHIPNews
ALL NEWS-
2024.09.10We will have a booth at BioJapan, a partnering event (Location: Pacifico Yokohama, October 9 (Wed) - 11 (Fri), 2024, 10:00-17:00). We will be located at booth area, booth number: B-33, so please stop by if you are interested in our activities.
-
2024.03.13March 13: We are pleased to announce that our founding director, Professor Hiroaki Suga at the University of Tokyo, received the Japan Academy Prize. This is a great accomplishment following his winning of the 2023 Wolf Prize for Chemistry last year. We would like to extend our sincere congratulations to him. For details of the Japan Academy Prize, please refer to the official website of the Japan Academy. https://www.japan-acad.go.jp/en/news/2024/031201.html
-
2024.02.16[Japanese only] Our founding director, Professor Hiroaki Suga at the University of Tokyo, is scheduled to speak at the Nikkei Business Innovation Forum to be held on March 15. Pre-registration is required, and there is no charge to attend. https://events.nikkei.co.jp/65515/
-
2024.01.30We participated in a partnering event, Biotech Showcase 2024 (Monday, January 8 - Wednesday, January 10, 2024 in San Francisco), where our CEO, Masuhiro Kato, gave a presentation. Please click on the link below to subscribe to the webcast and watch the video of the presentation.
-
2023.08.21We will have a booth at BioJapan, a partnering event (Location: Pacifico Yokohama, October 11 (Wed) - 13 (Fri), 2023, 10:00-17:00). We will be located at booth area, booth number: C-12, so please stop by if you are interested in our activities.
-
2023.07.01We have opened an official LinkdIn account for MiraBiologics, Inc. We will announce hot information about our company from time to time, so please follow us if you are interested.